Abstract:[Purpose] To investigate the effect and toxicity of weekly docetaxel combined with cisplatin for advanced non-small cell lung cancer(NSCLC).[Methods] Docetaxel combined with cisplatin was administered to forty six cases with advanced NSCLC.The patients received docetaxel 25mg/m2 on day 1,8,15 respectively and cisplatin 25mg/m2 on day 1 to 3.The schedule was repeated every 28 days.All patients received at least 2 cycles.[Results] Overall response rate was 39.13%(CR,2 cases;PR,16 cases;NC,17 cases;PD,11 cases).The response rate was significant difference between the initial treated group and retreated group(45.45% vs 33.33%,P0.05).The main toxicities were myelosuppression,nausea,vomiting and alopecia with majority of gradeⅠ or Ⅱ toxicity and well tolerated.Myelosuppression was dose-limiting toxicity and leukopenia accounted for 65.22%.[Conclusion] Weekly docetaxel combined with cisplatin is effective in the treatment for advanced non-small cell lung cancer,with mild to moderate toxicity and well tolerance.

An Analysis on Weekly Docetaxel Combined with Cisplatin for 46 Cases with Non-Small Cell Lung Cancer